| INTRODUCTION
Although metabolic abnormalities and obesity are known risk factors for cardiovascular disease (CVD), a subcategory of obesity without metabolic syndrome (MetS), referred to as metabolically healthy obesity (MHO) has yielded contradictory estimates of association with CVD.
1,2 MHO was associated with increased CVD risk in previous studies including four meta-analyses. [3] [4] [5] [6] [7] However, several individual studies did not find any association between MHO and CVD. [8] [9] [10] As this controversy about MHO and CVD continues, an examination of MHO and other obesity phenotypes with cardiovascular markers of poor outcomes may provide further evidence of more Izzah Vasim and Muhammad I. Ahmad contributed equally to this study.
proximal risks associated with these phenotypes. One such marker is the cardiac infarction/injury score (CIIS), an electrocardiographicbased scoring system used to define subclinical myocardial injury (SC-MI). 11 CIIS has been associated with future adverse events such as coronary heart disease (CHD), cardiovascular and all-cause mortality. [12] [13] [14] An examination of the association of obesity phenotypes with a marker of SC-MI using 12-lead electrocardiogram is a simple and cost-effective way to stratify the CVD risk associated with these phenotypes. Therefore, we sought to examine the cross-sectional association between obesity phenotypes and SC-MI in a sample from the third National Health and Nutrition Examination Survey (NHANES III) free of clinically diagnosed CVD. We hypothesized that obesity phenotypes (MUNO, MHO, and MUO) would be associated with prevalent SC-MI independent of potential confounders. We also conducted a subgroup analysis of the association between obesity phenotypes and SC-MI stratified by age (dichotomized at 65), sex and race (white vs non-white). The models were adjusted similarly to model 2 as mentioned above. in MUO participants. Table 1 shows baseline characteristics of participants stratified by nonobesity and obesity.
Among obesity group, MUO were more likely to be old, men, white, smokers, and to have low annual income and physical activity levels compared to MHO. Among the nonobesity group, MUNO were more likely to be old, women, white, nonsmokers, and to have low annual income and physical activity levels compared to MHNO.
In multivariable models adjusted for potential confounders, MUO was associated with higher odds of SC-MI (OR 1.53; 95% CI, 1.22-1.92, P = 0.0005). There was no statistically significant association between MHO or MUNO with SC-MI; However, a trend of higher odds of SC-MI was observed in MUNO (P-value for trend across MHNO, MUNO, and MUO = 0.0002) ( Table 2) . A similar pattern of association was observed when using CIIS as a continuous variable, as shown in Table 3 , there was a pattern of higher mean values in MUO followed by MUNO in multivariable linear regression models.
In subgroup analysis, heterogeneity in the association between obesity phenotypes and SC-MI was observed by sex. With MHNO as a reference, all obesity phenotypes and particularly MUO had a stron- (Table 4) . Table S2 and Figure 1 show the results of linear association of BMI with CIIS. Higher values of CIIS score were observed with increasing BMI independent of socio-demographic and CVD risk factors (trend P-value 0.22). malities. 18 Observation of higher CIIS with increasing BMI also suggests that excess weight is not without consequences and thus challenges the notion that obesity can be healthy.
MHO is considered a transient state; the duration and severity of obesity leads to an unhealthy state with the passage of time, thus We observed a strong association of obesity phenotypes with SC-MI among men. Men generally have a higher incidence of CHD and higher age-adjusted CHD mortality rate compared to women. [20] [21] [22] Our findings of gender differences in the association of SC-MI add to accumulating evidence of sex/gender differences in the prevalence and outcomes of different CVD. Future investigation should assess whether genetic background, emerging risk factors, access to health care, awareness, and adherence of medications contribute to sex differences.
In previous studies, MUNO had similar CVD risks as those with MUO. 3, 4 In support of these findings, we observed higher odds of SC-MI with MUNO, especially in men, suggesting that maintaining metabolic health remains important even in the absence of obesity. Finally, the MUO group has consistently exhibited an unfavorable prognosis in terms of CVD events and mortality across all studies, 3,4 likely due to the cumulative effect of obesity and MetS. A strong association of MUO with SC-MI in our study supports these findings.
Our study has certain limitations. First, we are unable to establish a temporal relationship between obesity phenotypes and SC-MI due to the cross-sectional design of the study; However, it is unlikely that SC-MI leads to obesity and Mets, but the opposite is more plausible.
Some of the measurements such as smoking and physical activity are self-reported and thus subject to recall bias. Finally, we adjusted for several confounders, but residual confounding remains a possibility.
Strengths of the study include a large sample size and a communityliving multiracial population with generalizability to the US population, as well as the fact that the key variables were ascertained using standard protocols.
| CONCLUSION
Our results in NHANES-III provide evidence that MetS may contribute to myocardial injury especially in those with obesity. Also, the higher the obesity class based on BMI, the higher is the risk of myocardial injury independent of MetS. With the increasing prevalence of obesity and MetS, it is important to identify high-risk populations so that finite resources can be allocated to appropriate groups.
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